AWE
CVS icon

Avidian Wealth Enterprises’s CVS Health CVS Stock Holding History

Avidian Wealth Enterprises’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$698K Buy
8,148
+848
+12% +$83K 0.02% 407
2026
Q2 		$755K Buy
7,300
+609
+9% +$54.4K 0.02% 387
2026
Q1 		$481K Buy
6,691
+154
+2% +$11.9K 0.02% 444
2025
Q4 		$519K Buy
6,537
+252
+4% +$19.9K 0.02% 365
2025
Q3 		$474K Buy
6,285
+214
+4% +$14.7K 0.02% 378
2025
Q2 		$419K Buy
6,071
+3,038
+100% +$199K 0.02% 375
2025
Q1 		$205K Buy
+3,033
New +$182K 0.01% 498
2024
Q2 		– Sell
-2,971
Closed -$237K – 506
2024
Q1 		$237K Buy
2,971
+272
+10% +$20.8K 0.01% 393
2023
Q4 		$213K Sell
2,699
-963
-26% -$68.5K 0.01% 393
2023
Q3 		$256K Sell
3,662
-1,114
-23% -$78.9K 0.02% 349
2023
Q2 		$330K Sell
4,776
-1,640
-26% -$117K 0.02% 328
2023
Q1 		$477K Buy
6,416
+867
+16% +$72.7K 0.03% 303
2022
Q4 		$517K Sell
5,549
-43
-0.8% -$4.15K 0.03% 270
2022
Q3 		$533K Sell
5,592
-213
-4% -$21.1K 0.04% 227
2022
Q2 		$538K Sell
5,805
-4,253
-42% -$415K 0.04% 252
2022
Q1 		$1.02M Sell
10,058
-9
-0.1% -$945 0.06% 193
2021
Q4 		$1.04M Buy
10,067
+6,374
+173% +$589K 0.06% 181
2021
Q3 		$313K Buy
3,693
+441
+14% +$36.9K 0.02% 287
2021
Q2 		$271K Buy
3,252
+221
+7% +$18.1K 0.02% 326
2021
Q1 		$228K Sell
3,031
-190
-6% -$13.8K 0.02% 325
2020
Q4 		$220K Buy
+3,221
New +$210K 0.02% 287
2020
Q1 		– Sell
-2,782
Closed -$207K – 220
2019
Q4 		$207K Buy
+2,782
New +$195K 0.03% 218

Other funds holding CVS

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
CAM
Cacti Asset Management Atlanta, Georgia $1.89B AUM 58.55% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Avidian Wealth Enterprises's CVS Position: Q3 2026 in Review

Avidian Wealth Enterprises increased its CVS Health (CVS) stake by 12% in Q3 2026, buying an estimated $83K and bringing the position to 8,148 shares worth $698K. The position accounts for 0.02% of the portfolio, ranked #407.

Avidian Wealth Enterprises first reported a position in CVS in Q4 2019 and has held it in 22 quarters since. The position peaked at $1.04M in Q4 2021. 87 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Avidian Wealth Enterprises held 8,148 shares of CVS Health worth $698K as of Q3 2026.
  • Avidian Wealth Enterprises bought 848 CVS Health shares in Q3 2026, an estimated $83K.
  • CVS Health made up 0.02% of Avidian Wealth Enterprises's portfolio in Q3 2026, its #407 holding.
  • Avidian Wealth Enterprises first reported a position in CVS Health in Q4 2019 and has held it in 22 quarters since.
  • Avidian Wealth Enterprises's CVS Health position peaked at $1.04M in Q4 2021.
  • 87 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q3 2026, filed 8 Oct 2026.